Post by Farmak International

✅ Farmak International has received another Marketing Authorisation in Spain. In July 2026, the Spanish Agency for Medicines and Medical Devices, AEMPS, granted Farmak International a new Marketing Authorisation for a hospital medicine in the cardiovascular therapeutic area. Since the beginning of the year, Farmak International has received several Marketing Authorisations in Spain, further developing its registered product portfolio in the country. Farmak International will continue to advance its regulatory projects and activities in the Spanish market.